Effect of disease states on α1 -adrenoceptor binding and signal transduction parameters in isolated perfused heart: quantification by pharmacokinetic-pharmacodynamic modelling
- PMID: 24237130
- DOI: 10.1111/jphp.12184
Effect of disease states on α1 -adrenoceptor binding and signal transduction parameters in isolated perfused heart: quantification by pharmacokinetic-pharmacodynamic modelling
Abstract
Objectives: To employ a pharmacokinetic-pharmacodynamic modelling approach for analysing the effect of experimental endotoxemia and mild hypoxia on α1 -adrenoceptor (α1 AR) binding and signal transduction.
Methods: In Langendorff-perfused rat hearts, phenylephrine was continuously infused, and [(3) H]-prazosin was injected as single dose (infused over 1 min). Simultaneous analysis of the time courses of prazosin outflow concentration and inotropic response (left ventricular developed pressure) using an agonist-antagonist interaction model and nonlinear regression allowed to estimate receptor affinity, as well as the parameters of the operational model of agonism.
Key findings: Both endotoxemia and hypoxia, significantly reduced the maximum response achievable in the system to 67% and 49% of the control group mean, respectively. In addition, endotoxemia decreased the efficiency of stimulus-response coupling and increased the steepness of the stimulus-response curve. In both disease models, no change in receptor affinity and density were found.
Conclusions: The results revealed the causes of reduced α1 AR-mediated inotropic responsiveness in endotoxemia and hypoxia. In contrast with traditional dose-response studies, it was possible to quantify separately the underlying changes in α1 AR binding and signal transduction.
Keywords: endotoxemia; hypoxia; inotropic response; perfused rat heart; α1-Adrenoceptor.
© 2013 Royal Pharmaceutical Society.
Similar articles
-
Modelling of alpha1-adrenoceptor-mediated temporal dynamics of inotropic response in rat heart to assess ligand binding and signal transduction parameters.Br J Pharmacol. 2009 Mar;156(5):764-73. doi: 10.1111/j.1476-5381.2008.00013.x. Epub 2009 Feb 13. Br J Pharmacol. 2009. PMID: 19220295 Free PMC article.
-
Pharmacokinetic-pharmacodynamic modeling of the effect of propofol on alpha 1-adrenoceptor-mediated positive inotropy in rat heart.Eur J Pharm Sci. 2009 Nov 5;38(4):389-94. doi: 10.1016/j.ejps.2009.09.006. Epub 2009 Sep 16. Eur J Pharm Sci. 2009. PMID: 19765653
-
Amyloid-β peptides activate α1-adrenergic cardiovascular receptors.Hypertension. 2013 Nov;62(5):966-72. doi: 10.1161/HYPERTENSIONAHA.113.01348. Epub 2013 Sep 3. Hypertension. 2013. PMID: 24001898
-
Myocardial alpha1-adrenoceptor: inotropic effect and physiologic and pathologic implications.Life Sci. 1997;60(16):1305-18. doi: 10.1016/s0024-3205(96)00650-9. Life Sci. 1997. PMID: 9096251 Review.
-
Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.J Mol Cell Cardiol. 2011 Oct;51(4):518-28. doi: 10.1016/j.yjmcc.2010.11.014. Epub 2010 Nov 28. J Mol Cell Cardiol. 2011. PMID: 21118696 Free PMC article. Review.
Cited by
-
The Effects of Dobutamine in Septic Shock: An Updated Narrative Review of Clinical and Experimental Studies.Medicina (Kaunas). 2024 Apr 30;60(5):751. doi: 10.3390/medicina60050751. Medicina (Kaunas). 2024. PMID: 38792934 Free PMC article. Review.
-
The spectrum of cardiovascular effects of dobutamine - from healthy subjects to septic shock patients.Rev Bras Ter Intensiva. 2017 Oct-Dec;29(4):490-498. doi: 10.5935/0103-507X.20170068. Rev Bras Ter Intensiva. 2017. PMID: 29340539 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials